In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti
M
M
Servizio Aggregato di Consulenze Infettivologiche, Dipartimento di Medicina Clinica, Università La Sapienza Rome and Istituto Superiore di Sanità, Rome, Italy.
Monaco
M
M
Micozzi
A
A
Tarasi
A
A
Friedrich
A
A
Martino
P
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001372:Aza Compounds; D016470:Bacteremia / Q000382:microbiology*; D001769:Blood / Q000382:microbiology; D024841:Fluoroquinolones; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D011804:Quinolines; D020615:Stenotrophomonas maltophilia / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin